ACE and coronary artery disorder: Nearly all (90%) of the premature CHD-affected male subjects were on statin treatment and over half of them (57%) used the angiotensin-converting enzyme inhibitor or angiotensin receptor II-blocking medication, the usage whereof was minor (5% in both cases) in the non-affected group.